Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis.
about
Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Influence of CYP2C9 and COX-2 ...... ent of Ankylosing Spondylitis.
@ast
Influence of CYP2C9 and COX-2 ...... ent of Ankylosing Spondylitis.
@en
Influence of CYP2C9 and COX-2 ...... ent of Ankylosing Spondylitis.
@nl
type
label
Influence of CYP2C9 and COX-2 ...... ent of Ankylosing Spondylitis.
@ast
Influence of CYP2C9 and COX-2 ...... ent of Ankylosing Spondylitis.
@en
Influence of CYP2C9 and COX-2 ...... ent of Ankylosing Spondylitis.
@nl
prefLabel
Influence of CYP2C9 and COX-2 ...... ent of Ankylosing Spondylitis.
@ast
Influence of CYP2C9 and COX-2 ...... ent of Ankylosing Spondylitis.
@en
Influence of CYP2C9 and COX-2 ...... ent of Ankylosing Spondylitis.
@nl
P2093
P2860
P356
P1476
Influence of CYP2C9 and COX-2 ...... ment of Ankylosing Spondylitis
@en
P2093
P2860
P304
P356
10.12659/MSM.900271
P577
2017-04-12T00:00:00Z